; and (B) beginning with the first registration or renewal of registration by the practitioner under this section occurring 90 or more days after the date of enactment of the Medication Access and Training Expansion Act of 2019 . (2) Training required As a condition on registration under this section to dispense controlled substances in schedule II, III, IV, or V, the Attorney General shall require any practitioner described in paragraph (1)(A) to meet the following: (A) If the practitioner is a physician, the practitioner must meet one or more of the following conditions: (i) The physician holds a board certification in addiction psychiatry or addiction medicine from the American Board of Medical Specialties. (ii) The physician holds an addiction certification or board certification from the American Society of Addiction Medicine or the American Board of Addiction Medicine. (iii) The physician holds a board certification in addiction medicine from the American Osteopathic Association. (iv) The physician has, with respect to the treatment and management of patients with opioid and other substance use disorders, completed not less than 8 hours of training (through classroom situations, seminars at professional society meetings, electronic communications, or otherwise) that is provided by the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Psychiatric Association, or any other organization that the Secretary determines is appropriate for purposes of this clause. Such training shall include— (I) opioid maintenance and detoxification; (II) appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder; (III) initial and periodic patient assessments (including substance use monitoring); (IV) individualized treatment planning, overdose reversal, and relapse prevention; (V) counseling and recovery support services